Approval · Notice of Compliance 22242 · 2019
POLYFLEX: Notice of Compliance 22242
Issued June 6, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22242
- Date
- June 6, 2019
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing change
Products in this notice
Medicinal ingredients
- AMPICILLIN TRIHYDRATE 10 G per VIAL
- AMPICILLIN TRIHYDRATE 25 G per VIAL